MarketPeel
Insider Trading Intelligence
PP

Purav Patel

RVPH
DIRECTOR · REVIVA PHARMACEUTICALS HOLDINGS, INC. · CIK 0001818246
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$14.1K
COMPANIES
1
ACTIVE SINCE
Apr 2021
HOLDINGS NOW
8,200
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Purav Patel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-14.59%+1.59%-16.18%-16.18%
14d1+0.00%-22.32%+2.75%-25.07%-25.07%
30d1+0.00%-25.32%-3.60%-21.72%-21.72%
60d1+0.00%-2.79%+0.90%-3.69%-3.69%
90d1+0.00%-1.50%+3.57%-5.07%-5.07%
180d1+100.00%+71.25%+5.73%+65.51%+65.51%
1y1+0.00%-13.95%+15.62%-29.57%-29.57%
2y1+0.00%-72.75%+52.89%-125.64%-125.64%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RVPH · 8,200 shares · as of Dec 18, 2025
010,88721,77432,66043,5472022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 8 buys / 0 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
8,2008,200Dec 18, 2025Dec 19, 2025View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
8,2008,200Dec 10, 2024Dec 12, 2024View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
8,2008,200Nov 13, 2023Nov 14, 2023View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
3,000$4.69$14.1K43,547Nov 18, 2022Nov 21, 2022View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,9003,900Nov 10, 2022Nov 14, 2022View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,3005,300Dec 8, 2021Dec 10, 2021View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,0004,000Jun 15, 2021Jun 16, 2021View →
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
15,22715,227Apr 14, 2021Apr 15, 2021View →
Other insiders · RVPH
Loading peer insiders…
About this filer
CIK 0001818246
ROLE
Director
PRIMARY
RVPH
COMPANIES
1
ACTIVE SINCE
Apr 2021
MARKETPEEL · /INSIDER/0001818246DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback